Is CSX a Good Investment at the Moment?

Is CSX Corp A Good Stock to Buy?CSX Corporation (NYSE:CSX), a $22 billion market cap railroad with a focus on the eastern U.S., reported its third quarter results this week. Revenue declined very slightly, after the company having seen top-line growth in the first half of 2012 versus the same period in 2011. A similar story held up for earnings: net income was down 2% in the quarter from a year earlier, while CSX had grown its earnings when looking at the first and second quarters combined. However, because CSX has been active in buying back shares, earnings per share ticked up a penny. EPS for the first nine months of the year came in at $1.36, a 10% increase from the first three quarters of last year. According to the company, $200 million worth of shares were repurchased last quarter.

The trends at CSX Corporation’s business don’t look particularly good, but there is an argument that the stock makes up for it with its cheap pricing. Its trailing P/E is 12, and keep in mind that earnings per share were about flat last quarter even with revenue coming in lower. In addition to share repurchases, the company pays a 2.6% dividend yield to further demonstrate returning cash to shareholders. Analyst consensus for earnings in 2013 imply a forward P/E of 10, and we think that the business should be stable enough to justify a higher multiple than that.

Robert Bishop’s Impala Asset Management more than doubled the size of its position in CSX Corporation during the second quarter, with the fund reporting a total of 3 million shares in its portfolio at the end of June. This made it one of Impala’s 10 largest 13F positions (see more stock picks from Impala Asset Management). Valinor Asset Management, managed by David Gallo, also increased its stake and owned 2 million shares at the end of the quarter (research more stocks that Valinor owns). Adage Capital Management, run by former Harvard Management employees Phil Gross and Robert Atchinson, sold shares on net but still had 1.3 million shares (find stocks that Adage has been buying and selling).

Norfolk Southern Corp. (NYSE:NSC) and Union Pacific Corporation (NYSE:UNP) are two other large publicly traded U.S. railroads which therefore make good peers for CSX. Norfolk Southern is about the same size in terms of market cap, and its trailing and forward P/E multiples both come in at 11 so it is roughly even with CSX in terms of valuation on that basis. In the second quarter of the year its revenue was about flat but earnings were down 6%, worse than CSX seems to have done in the same quarter. We think both companies are about even from a value perspective. The larger Union Pacific- its market cap is about $60 billion- experienced substantial growth in both revenue and earnings in the second quarter versus a year earlier; however, it carries a small premium to these other two railroads at a trailing P/E of 16 and a forward P/E of 13, and its dividend yield is a bit lower. We think its higher pricing is about the right level for the degree to which it is a better-performing business.

We can also compare CSX to smaller railroads Kansas City Southern (NYSE:KSU) and Genesee & Wyoming Inc. (NYSE:GWR). Possibly because of their prospects as acquisitions, these companies are much higher priced: they trade at 19 and 17 times forward earnings estimates, respectively. They did both see double-digit earnings growth in the second quarter compared to the same period in the previous year, but revenue growth was considerably lower and we don’t think the bottom-line growth is sustainable. As smaller companies which are not particularly more attractive on a performance basis and which are more expensive, we don’t think they are as good values as the larger railroads. However, we would also avoid shorting them due to the possibility of acquisitions.

CSX looks like a good value stock after its earnings. However, other large railroads such as Norfolk Southern and Union Pacific seem like they may be just as good buys and investors should watch those companies’ quarterly reports as well.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!